Allison W. Kurian

22.8k total citations · 5 hit papers
293 papers, 9.8k citations indexed

About

Allison W. Kurian is a scholar working on Genetics, Oncology and Cancer Research. According to data from OpenAlex, Allison W. Kurian has authored 293 papers receiving a total of 9.8k indexed citations (citations by other indexed papers that have themselves been cited), including 141 papers in Genetics, 130 papers in Oncology and 115 papers in Cancer Research. Recurrent topics in Allison W. Kurian's work include BRCA gene mutations in cancer (136 papers), Breast Cancer Treatment Studies (66 papers) and Global Cancer Incidence and Screening (57 papers). Allison W. Kurian is often cited by papers focused on BRCA gene mutations in cancer (136 papers), Breast Cancer Treatment Studies (66 papers) and Global Cancer Incidence and Screening (57 papers). Allison W. Kurian collaborates with scholars based in United States, Canada and United Kingdom. Allison W. Kurian's co-authors include James M. Ford, Christina A. Clarke, Theresa H.M. Keegan, Steven J. Katz, Ann S. Hamilton, Scarlett Lin Gomez, Kevin C. Ward, Sylvia K. Plevritis, Nadia Howlader and Reshma Jagsi and has published in prestigious journals such as Cell, JAMA and Nature Communications.

In The Last Decade

Allison W. Kurian

272 papers receiving 9.6k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Structured Tumor-Immune Microenvironment in Triple Negative Breast Cancer Revealed by Multiplexed Ion Beam Imaging

2018 653 citations Allison W. Kurian, Robert B. West et al. profile →
Differences in Breast Cancer Survival by Molecular Subtypes in the United States

2018 389 citations Allison W. Kurian et al. Cancer Epidemiology Biomarkers & Prevention profile →
Analysis of Breast Cancer Mortality in the US—1975 to 2019

2024 89 citations Allison W. Kurian, Sylvia K. Plevritis et al. profile →
Germline Testing in Patients With Breast Cancer: ASCO–Society of Surgical Oncology Guideline

2024 67 citations Allison W. Kurian et al. Journal of Clinical Oncology profile →
Germline Genetic Testing After Cancer Diagnosis

2023 66 citations Allison W. Kurian, Paul Abrahamse et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Allison W. Kurian United States	56	4.0k	3.9k	3.6k	2.2k	1.4k	293	9.8k
Timothy R. Rebbeck United States	56	3.7k 0.9×	5.6k 1.4×	2.7k 0.7×	3.0k 1.4×	1.6k 1.1×	257	12.7k
Andrea Eisen Canada	49	3.1k 0.8×	4.9k 1.3×	2.9k 0.8×	1.6k 0.7×	1.5k 1.0×	189	8.3k
Claudine Isaacs United States	63	4.8k 1.2×	7.9k 2.0×	3.7k 1.0×	2.7k 1.2×	2.0k 1.4×	279	13.8k
Elżbieta Senkus Poland	35	6.2k 1.5×	1.8k 0.5×	4.0k 1.1×	2.3k 1.0×	1.2k 0.8×	113	10.1k
Karen N. Price Switzerland	50	5.8k 1.5×	2.6k 0.7×	4.9k 1.4×	1.4k 0.6×	1.6k 1.1×	103	9.1k
Gong Tang United States	34	4.8k 1.2×	1.6k 0.4×	6.1k 1.7×	2.6k 1.2×	1.5k 1.1×	112	10.0k
Melissa A. Troester United States	45	5.4k 1.3×	1.6k 0.4×	4.6k 1.3×	3.7k 1.6×	984 0.7×	275	10.7k
Michael Baum United Kingdom	53	6.3k 1.6×	3.5k 0.9×	5.8k 1.6×	2.2k 1.0×	1.6k 1.1×	283	13.3k
Ellen Warner Canada	40	3.6k 0.9×	2.7k 0.7×	2.2k 0.6×	860 0.4×	1.6k 1.1×	198	8.3k
Maureen Trudeau Canada	52	7.4k 1.9×	1.4k 0.4×	5.0k 1.4×	3.1k 1.4×	1.4k 0.9×	259	12.8k

Countries citing papers authored by Allison W. Kurian

Since Specialization

Citations

This map shows the geographic impact of Allison W. Kurian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Allison W. Kurian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Allison W. Kurian more than expected).

Fields of papers citing papers by Allison W. Kurian

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Allison W. Kurian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Allison W. Kurian. The network helps show where Allison W. Kurian may publish in the future.

Co-authorship network of co-authors of Allison W. Kurian

This figure shows the co-authorship network connecting the top 25 collaborators of Allison W. Kurian. A scholar is included among the top collaborators of Allison W. Kurian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Allison W. Kurian. Allison W. Kurian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kurian, Allison W., Allison Furgal, Archana Radhakrishnan, et al.. (2025). Extended endocrine therapy use and decision making after breast cancer diagnosis. JNCI Journal of the National Cancer Institute. 117(8). 1573–1582.

Katz, Steven J., Paul Abrahamse, Allison Furgal, et al.. (2024). Genetic Counseling, Testing, and Family Communication Into Survivorship After Diagnosis of Breast Cancer. Journal of Clinical Oncology. 42(26). 3123–3129. 2 indexed citations

John, Esther M., et al.. (2024). Reproductive characteristics, menopausal status, race and ethnicity, and risk of breast cancer subtypes defined by ER, PR and HER2 status: the Breast Cancer Etiology in Minorities study. Breast Cancer Research. 26(1). 88–88. 2 indexed citations

Thompson, Caroline A., Paige Sheridan, Sharon Peacock Hinton, et al.. (2024). Emergency department involvement in the diagnosis of cancer among older adults: a SEER-Medicare study. JNCI Cancer Spectrum. 8(3). 7 indexed citations

Liu, Benmei, et al.. (2024). Receipt of guideline-concordant care and survival among young adult women with non-metastatic breast cancer. Breast Cancer Research and Treatment. 210(2). 347–354.

John, Esther M., Jocelyn Koo, Sue A. Ingles, Allison W. Kurian, & Lisa M. Hines. (2023). Changes in Breast Cancer Risk and Risk Factor Profiles among U.S.-Born and Immigrant Asian American Women Residing in the San Francisco Bay Area. Cancer Epidemiology Biomarkers & Prevention. 32(5). 666–677. 3 indexed citations

Lin, Grace A., Julia R. Trosman, Michael P. Douglas, et al.. (2021). Influence of payer coverage and out‐of‐pocket costs on ordering of NGS panel tests for hereditary cancer in diverse settings. Journal of Genetic Counseling. 31(1). 130–139. 21 indexed citations

Hall, Michael J., Ryan Bernhisel, Elisha Hughes, et al.. (2021). Germline Pathogenic Variants in the Ataxia Telangiectasia Mutated ( ATM ) Gene are Associated with High and Moderate Risks for Multiple Cancers. Cancer Prevention Research. 14(4). 433–440. 102 indexed citations

Shariff‐Marco, Salma, Libby Ellis, Juan Yang, et al.. (2020). Hospital Characteristics and Breast Cancer Survival in the California Breast Cancer Survivorship Consortium. JCO Oncology Practice. 16(6). e517–e528. 9 indexed citations

10.

Afghahi, Anosheh, Natasha Purington, Summer S. Han, et al.. (2018). Higher Absolute Lymphocyte Counts Predict Lower Mortality from Early-Stage Triple-Negative Breast Cancer. Clinical Cancer Research. 24(12). 2851–2858. 67 indexed citations

11.

Rafat, Marjan, Todd A. Aguilera, Marta Vilalta, et al.. (2018). Macrophages Promote Circulating Tumor Cell–Mediated Local Recurrence following Radiotherapy in Immunosuppressed Patients. Cancer Research. 78(15). 4241–4252. 38 indexed citations

12.

Lin, Chieh‐Yu, Daphne Y. Lichtensztajn, Scarlett Lin Gomez, et al.. (2017). Regional Variability in Percentage of Breast Cancers Reported as Positive for HER2 in California. American Journal of Clinical Pathology. 148(3). 199–207. 8 indexed citations

13.

Wu, Jia, Yi Cui, Xiaoli Sun, et al.. (2017). Unsupervised Clustering of Quantitative Image Phenotypes Reveals Breast Cancer Subtypes with Distinct Prognoses and Molecular Pathways. Clinical Cancer Research. 23(13). 3334–3342. 77 indexed citations

14.

Sposto, Richard, Theresa H.M. Keegan, Cheryl Vigen, et al.. (2016). The Effect of Patient and Contextual Characteristics on Racial/Ethnic Disparity in Breast Cancer Mortality. Cancer Epidemiology Biomarkers & Prevention. 25(7). 1064–1072. 22 indexed citations

15.

Cheng, Iona, Salma Shariff‐Marco, Jocelyn Koo, et al.. (2015). Contribution of the Neighborhood Environment and Obesity to Breast Cancer Survival: The California Breast Cancer Survivorship Consortium. Cancer Epidemiology Biomarkers & Prevention. 24(8). 1282–1290. 27 indexed citations

16.

Kurian, Allison W., Aya Mitani, Manisha Desai, et al.. (2013). Breast cancer treatment across health care systems: Linking electronic medical records and state registry data to enable outcomes research. Cancer. 120(1). 103–111. 47 indexed citations

17.

Keegan, Theresa H.M., Mindy C. DeRouen, David J. Press, Allison W. Kurian, & Christina A. Clarke. (2012). Occurrence of breast cancer subtypes in adolescent and young adult women. Breast Cancer Research. 14(2). R55–R55. 197 indexed citations

18.

Sigal, Bronislava M., et al.. (2012). A Simulation Model to Predict the Impact of Prophylactic Surgery and Screening on the Life Expectancy of BRCA1 and BRCA2 Mutation Carriers. Cancer Epidemiology Biomarkers & Prevention. 21(7). 1066–1077. 30 indexed citations

19.

Kurian, Allison W., Bronislava M. Sigal, & Sylvia K. Plevritis. (2009). Survival Analysis of Cancer Risk Reduction Strategies for BRCA1/2 Mutation Carriers. Journal of Clinical Oncology. 28(2). 222–231. 167 indexed citations

20.

Kurian, Allison W., et al.. (2007). A Cost-Effectiveness Analysis of Adjuvant Trastuzumab Regimens in Early HER2/neu–Positive Breast Cancer. Journal of Clinical Oncology. 25(6). 634–641. 92 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact